← Evidence map

TrialJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners2021

Glasdegib plus low-dose cytarabine for acute myeloid leukemia: Practical considerations from advanced practitioners and pharmacists.

Valerie Relias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2021
2022
2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33215562